16-2300067-C-T
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_001089.3(ABCA3):c.1549G>A(p.Glu517Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000201 in 1,613,684 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001089.3 missense
Scores
Clinical Significance
Conservation
Publications
- interstitial lung disease due to ABCA3 deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA3 | ENST00000301732.10 | c.1549G>A | p.Glu517Lys | missense_variant | Exon 13 of 33 | 1 | NM_001089.3 | ENSP00000301732.5 | ||
ABCA3 | ENST00000382381.7 | c.1375G>A | p.Glu459Lys | missense_variant | Exon 12 of 32 | 1 | ENSP00000371818.3 | |||
ABCA3 | ENST00000563623.5 | n.2112G>A | non_coding_transcript_exon_variant | Exon 13 of 20 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000382 AC: 58AN: 151770Hom.: 1 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.000203 AC: 51AN: 251444 AF XY: 0.000199 show subpopulations
GnomAD4 exome AF: 0.000182 AC: 266AN: 1461796Hom.: 0 Cov.: 32 AF XY: 0.000166 AC XY: 121AN XY: 727190 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000382 AC: 58AN: 151888Hom.: 1 Cov.: 30 AF XY: 0.000445 AC XY: 33AN XY: 74234 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Glu517Lys varia nt in ABCA3 has not been previously identified in individuals with pulmonary dis ease. This variant has been identified in 1/8600 European American chromosomes b y the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP r s201157181). Glutamic acid (Glu) at position 517 is poorly conserved in evolutio n and at least 2 mammals (tarsier and alpaca) carry the variant amino acid, rais ing the possibility that this change may be tolerated. Additional computational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) sug gest that the Glu517Lys variant may not impact the protein, though this informat ion is not predictive enough to rule out pathogenicity. In summary, this variant is less likely disease causing but additional information is needed to fully as sess its clinical significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at